Silence Therapeutics Plc American Depository Share Quarterly Cash Flow Statement
NASDAQ: SLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Silence Therapeutics Plc American Depository Share free cash flow
In the quarter ended Jun 30, 2026, Silence Therapeutics Plc American Depository Share generated $1.5 million of operating cash flow and spent $0 on capital expenditures. That left free cash flow of $1.5 million.
Summary generated from market data by MetaCap's automated system. Methodology
Silence Therapeutics Plc American Depository Share cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -12.27M | -14.96M | -11.77M | -20.96M | -27.35M | -28.53M | 12.30M | -35.54M | -19.75M | -2.31M |
| Net Income growth (YoY) | — | — | -195.68% | — | — | — | — | — | — | — |
| Depreciation & Amortization | 73.00K | 72.00K | 77.00K | 81.00K | 81.00K | 73.00K | 76.00K | 86.00K | 86.00K | 88.00K |
| Stock-Based Compensation | 1.31M | 2.45M | -86.00K | 2.54M | 2.08M | 3.54M | 3.98M | 4.07M | 4.14M | 4.12M |
| Change in Working Capital | 0 | -404.00K | -2.00K | -26.00K | -150.00K | 868.00K | -24.77M | 1.07M | 9.54M | -15.53M |
| Operating Cash Flow | 1.52M | -15.60M | -17.29M | -10.89M | -21.78M | -12.31M | -27.48M | -25.61M | -5.41M | -9.14M |
| Capital Expenditures | 0 | 0 | 0 | -3.00K | -48.00K | -4.00K | -62.00K | -64.00K | -85.00K | 0 |
| Investing Cash Flow | 64.94M | 10.00M | -53.34M | 51.29M | -1.56M | -44.38M | 66.13M | -38.14M | -43.00K | -49.91M |
| Financing Cash Flow | 2.00K | 0 | 0 | 0 | 1.00K | 14.00K | -98.00K | 7.97M | 1.19M | 133.02M |
| Net Change in Cash | 66.46M | -5.60M | -70.63M | 40.40M | -23.34M | -56.68M | 38.55M | -55.77M | -4.26M | 73.97M |
| Free Cash Flow | 1.52M | -15.60M | -17.29M | -10.89M | -21.83M | -12.31M | -27.54M | -25.67M | -5.49M | -9.14M |
This table shows 10 quarterly periods of Silence Therapeutics Plc American Depository Share's cash flow statement, from Q2 2026 back to Q1 2024, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SLN's reporting calendar. What is a cash flow statement?